Spots Global Cancer Trial Database for adult acute lymphoblastic leukemia
Every month we try and update this database with for adult acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia | NCT02072785 | Adult Acute Lym... | Vincristine Sul... Vincristine Sul... | 18 Years - 65 Years | Nanjing Luye Sike Pharmaceutical Co., Ltd. | |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | NCT03564704 | Leukemia Leukemia, Acute Adult Lymphobla... Leukemia, Lymph... Leukemia, T Cel... Adult Acute Lym... Lymphoblastic L... Lymphoblastic L... | Dexamethasone vincristine Cyclophosphamid... Idarubicin Pegaspargase Adriamycin Methotrexate 6-mercaptopurin... Etoposide Cytarabine Bone marrow asp... Intrathecal inj... Radiation thera... NGS allogeneic hema... Flow-MRD FISH Flow immunophen... Karyotyping Chidamide PET-CT scan | 14 Years - 55 Years | Nanfang Hospital, Southern Medical University | |
| A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL | NCT05026229 | Precursor Cell ... Philadelphia-Po... ALL, Adult | dasatinib plus ... dasatinib plus ... | 18 Years - 65 Years | First Affiliated Hospital Xi'an Jiaotong University | |
| Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia | NCT00993135 | Leukemia Renal Toxicity | methotrexate medical chart r... assessment of t... | - 21 Years | Vanderbilt University Medical Center | |
| Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant | NCT01251575 | Adult Acute Lym... Adult Acute Mye... Adult Diffuse L... Adult Myelodysp... Adult Non-Hodgk... Aggressive Non-... Childhood Acute... Childhood Acute... Childhood Diffu... Childhood Myelo... Childhood Non-H... Chronic Lymphoc... Chronic Lymphoc... Chronic Phase C... Hematopoietic a... Mantle Cell Lym... Plasma Cell Mye... Prolymphocytic ... Recurrent Chron... Refractory Chro... T-Cell Prolymph... Waldenstrom Mac... Recurrent Diffu... Recurrent Hodgk... | Allogeneic Hema... Cyclosporine Fludarabine Pho... Laboratory Biom... Mycophenolate M... Peripheral Bloo... Sirolimus Total-Body Irra... | - | Fred Hutchinson Cancer Center | |
| Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia | NCT01284010 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymerase chai... laboratory biom... | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00651261 | Leukemia | cytarabine daunorubicin midostaurin placebo dexamethasone a... | 18 Years - 59 Years | Alliance for Clinical Trials in Oncology | |
| Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant | NCT01251575 | Adult Acute Lym... Adult Acute Mye... Adult Diffuse L... Adult Myelodysp... Adult Non-Hodgk... Aggressive Non-... Childhood Acute... Childhood Acute... Childhood Diffu... Childhood Myelo... Childhood Non-H... Chronic Lymphoc... Chronic Lymphoc... Chronic Phase C... Hematopoietic a... Mantle Cell Lym... Plasma Cell Mye... Prolymphocytic ... Recurrent Chron... Refractory Chro... T-Cell Prolymph... Waldenstrom Mac... Recurrent Diffu... Recurrent Hodgk... | Allogeneic Hema... Cyclosporine Fludarabine Pho... Laboratory Biom... Mycophenolate M... Peripheral Bloo... Sirolimus Total-Body Irra... | - | Fred Hutchinson Cancer Center | |
| Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia | NCT01284010 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymerase chai... laboratory biom... | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia | NCT00993135 | Leukemia Renal Toxicity | methotrexate medical chart r... assessment of t... | - 21 Years | Vanderbilt University Medical Center | |
| Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer | NCT00295880 | Myeloproliferat... Leukemia Lymphoma Myelodysplastic... | umbilical cord ... | 12 Years - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00651261 | Leukemia | cytarabine daunorubicin midostaurin placebo dexamethasone a... | 18 Years - 59 Years | Alliance for Clinical Trials in Oncology | |
| Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia | NCT00537030 | Adult Acute Lym... Childhood Acute... | Asparaginase Laboratory Biom... Pharmacological... | 1 Year - 30 Years | Children's Oncology Group | |
| Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients | NCT03419494 | Adult Acute Lym... | PLD DNR | 14 Years - 60 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia | NCT01079507 | Acute Lymphobla... | 18 Years - | Samsung Medical Center | ||
| Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria | NCT00112983 | Leukemia | eculizumab | 18 Years - | National Cancer Institute (NCI) | |
| Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia | NCT00537030 | Adult Acute Lym... Childhood Acute... | Asparaginase Laboratory Biom... Pharmacological... | 1 Year - 30 Years | Children's Oncology Group | |
| Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia | NCT02072785 | Adult Acute Lym... | Vincristine Sul... Vincristine Sul... | 18 Years - 65 Years | Nanjing Luye Sike Pharmaceutical Co., Ltd. | |
| Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia | NCT00188084 | Adult Acute Lym... | DNA Index S-Phase% CD45 expression P16 metabolic w... | 15 Years - 59 Years | University Hospital, Angers | |
| A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL | NCT05026229 | Precursor Cell ... Philadelphia-Po... ALL, Adult | dasatinib plus ... dasatinib plus ... | 18 Years - 65 Years | First Affiliated Hospital Xi'an Jiaotong University | |
| Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia | NCT00537030 | Adult Acute Lym... Childhood Acute... | Asparaginase Laboratory Biom... Pharmacological... | 1 Year - 30 Years | Children's Oncology Group | |
| A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL | NCT05026229 | Precursor Cell ... Philadelphia-Po... ALL, Adult | dasatinib plus ... dasatinib plus ... | 18 Years - 65 Years | First Affiliated Hospital Xi'an Jiaotong University | |
| A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL | NCT05024357 | Precursor Cell ... Philadelphia-Po... ALL, Adult | Dasatinib | 18 Years - 65 Years | First Affiliated Hospital Xi'an Jiaotong University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
